Research Article: Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation
Introduction:
Hepatocellular carcinoma (HCC), the sixth most common cancer and the third leading cause of cancer-related death globally, has emerged as a major public health concern. China experiences the highest incidence of HCC, accounting for over half of new cases and deaths worldwide. , As a first-line treatment for early-stage HCC, local ablation exhibits the advantages of small trauma, less bleeding, and fewer complications. However, despite the presence of some strengths, the high recurrence rate of local ablation…
Read more